Live Breaking News & Updates on Director Medical Initiatives

Press release content from Business Wire. The AP news staff was not involved in its creation.
NOXXON Appoints Leading Pancreatic Cancer Experts to Scientific Advisory Board
February 8, 2021 GMT
Regulatory News:
NOXXON Pharma N.V.
(Euronext Growth Paris: ALNOX), a biotechnology company focused on improving cancer treatments by targeting the tumor microenvironment (TME), announced today the appointment of four leading pancreatic cancer experts to its Scientific Advisory Board (SAB). Led by the newly appointed Chair, Dr. Jose Saro, the SAB will provide strategic and scientific counsel to NOXXON’s clinical programs in this indication.
“These prominent research leaders bring long-standing clinical expertise, cutting-edge scientific knowledge, and a track record of successfully developing new drugs to treat this devastating disease. They fully understand the challenges of developing new drugs for pancreas cancer where the tumor microenvironment plays a large ....

United States , France General , Ulf Jungnelius , Wissenschaftlichen Medizinischen Fachgesellschaften , Gabriela Chiorean , Arthur Rouill , Valeria Fisher , Aram Mangasarian , Pharmanv Euronext , Jose Saro , Weill Cornell Medical College , University Of Ulm , Davidm Rubenstein Center , Pancreatic Cancer Task , Innovative Cancer Research , German Cancer Society Deutschen Krebsgesellschaft , Cancer Research Network , Uw Medicine Fred Hutchinson Cancer Research Center , Seattle Cancer Care Alliance , Pancreatic Cancer Research Team , Clinical Research , Gastrointestinal Oncology Program , Honor Health Research Institute , Fred Hutchinson Cancer Research Center , European Society For Digestive Oncology , Certification Commission Of Visceral Oncology Centers ,